Onesource Specialty Pharma Ltd. (ONESOURCE.NS) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-475.2%

-₹5,877.75

vs ₹1,566.70 price

Levered DCF

-₹12,800.91

After debt service

Piotroski score

2 / 9

Weak

Altman Z-score

4.26

Safe zone

Rating

C-

Overall 1 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022
P/E	-228.63×	-85,298.43×	-50.03×	-24.47×
P/B	2.89×	3.06×	49.45×	24.91×
P/S	11.87×	12.45×	113.82×	505.46×
EV / EBITDA	60.09×	52.01×	-108.88×	-78.14×
Gross margin	32.0%	69.9%	59.0%	47.3%
Operating margin	1.8%	13.2%	-91.0%	-557.6%
Net margin	-5.2%	-0.0%	-227.5%	-2066.0%
Current ratio	0.99×	0.98×	0.28×	0.26×
Debt / equity	0.26×	0.16×	1.44×	1.1×
Interest coverage	0.21×	1.24×	-1.83×	-5.38×
Dividend yield	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022
Return on equity	-1.3%	-0.0%	-98.9%	-101.8%
Return on invested capital	0.3%	0.7%	-16.1%	-13.1%
Return on assets	-0.9%	-0.0%	-29.9%	-39.8%
Free cash flow yield	-4.0%	-1.1%	-0.9%	-1.1%
Earnings yield	-0.4%	-0.0%	-2.0%	-4.1%
Enterprise value	₹182.8B	₹187.7B	₹201.3B	₹204.3B
Net debt / EBITDA	4.62×	2.18×	-3.05×	-3.29×
Cash conversion cycle (days)	202	98	-203	722